For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com  Inclusion Criteria:  Oncologists from Spain and Portugal will be identified by the promoter and invited to participate in the study in accordance with the inclusion criteria described below.  The oncologist is currently working in a Spanish or Portuguese public hospital. The oncologist has at least 2 years of experience in the management of participants with Renal Cell Carcinoma (RCC). The oncologist has agreed to participate in the study.  Participants with a diagnosis of RCC will be identified and recruited by the Principal Investigators of the study, taking into account the inclusion criteria described below.  The participant has been diagnosed with RCC for a minimum of 2 months before study inclusion. The participant has received or is currently receiving pharmacological treatment for RCC; The participant has provided the informed consent to participate in the study. The participant must be able to read, understand and complete the survey instrument according to the judgment of the responsible physician.  Exclusion Criteria:  • Not applicable